Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
about
TRAP1: a viable therapeutic target for future cancer treatments?5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor.Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development.Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor.Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
P2860
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@ast
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@en
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@nl
type
label
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@ast
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@en
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@nl
prefLabel
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@ast
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@en
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@nl
P2860
P1476
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
@en
P2093
Daniel T Gewirth
P2860
P304
P356
10.2174/1568026616666160413141154
P407
P577
2016-01-01T00:00:00Z